scholarly article | Q13442814 |
P50 | author | Elizabeth Barrett-Connor | Q37322423 |
Diabetes Prevention Program Research Group | Q47171583 | ||
P2093 | author name string | Catherine Kim | |
John F Randolph | |||
Kieren J Mather | |||
Bin Nan | |||
Shengchun Kong | |||
Sherita H Golden | |||
P2860 | cites work | Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin | Q22250892 |
Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity | Q29614932 | ||
Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution | Q33909569 | ||
Relationships of circulating sex hormone-binding globulin with metabolic traits in humans | Q34355301 | ||
Lifestyle intervention and coronary heart disease risk factor changes over 18 months in postmenopausal women: the Women On the Move through Activity and Nutrition (WOMAN study) clinical trial. | Q34572347 | ||
Higher serum free testosterone concentration in older women is associated with greater bone mineral density, lean body mass, and total fat mass: the cardiovascular health study | Q34758514 | ||
Endogenous sex hormone changes in postmenopausal women in the diabetes prevention program | Q36134744 | ||
Do changes in sex steroid hormones precede or follow increases in body weight during the menopause transition? Results from the Study of Women's Health Across the Nation | Q36201486 | ||
Reductions in glucose among postmenopausal women who use and do not use estrogen therapy | Q36639667 | ||
The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women | Q37385026 | ||
Effects of HRT and exercise training on insulin action, glucose tolerance, and body composition in older women | Q43610712 | ||
Body composition, visceral fat distribution and fat oxidation in postmenopausal women using oral or transdermal oestrogen | Q44577925 | ||
Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause | Q46297503 | ||
Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators | Q47309980 | ||
Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study. | Q51494027 | ||
Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women--a clinical research center study. | Q51581009 | ||
Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. | Q52719647 | ||
Effect of menopausal status on body composition and abdominal fat distribution | Q73510827 | ||
Differential impact of conventional oral or transdermal hormone replacement therapy or tibolone on body composition in postmenopausal women | Q77130283 | ||
Adipose tissue as an endocrine and paracrine organ | Q77758550 | ||
Postmenopausal sex hormones in relation to body fat distribution | Q83222329 | ||
P433 | issue | 3 | |
P304 | page(s) | 882-887 | |
P577 | publication date | 2013-08-23 | |
P1433 | published in | Obesity | Q15763232 |
P1476 | title | Sex steroid levels and response to weight loss interventions among postmenopausal women in the diabetes prevention program | |
P478 | volume | 22 |
Q27023901 | Endogenous sex hormones, metabolic syndrome, and diabetes in men and women | cites work | P2860 |
Search more.